Literature DB >> 18414135

Brain hyperthermia after traumatic brain injury does not reduce brain oxygen.

Alejandro M Spiotta1, Michael F Stiefel, Gregory G Heuer, Stephanie Bloom, Eileen Maloney-Wilensky, Wei Yang, M Sean Grady, Peter D Le Roux.   

Abstract

OBJECTIVE: Hyperthermia can exacerbate outcome after traumatic brain injury (TBI). In this study, we examined the relationship between brain temperature (BT) and core body temperature and the relationship between BT and brain tissue oxygen (BtO2) to determine whether hyperthermia adversely affects BtO2.
METHODS: Seventy-two patients (mean age, 41 +/- 19 years) admitted to a Level I trauma center after TBI were retrospectively identified from a prospective observational database. Intracranial pressure (ICP), BT, and BtO2 were recorded continuously. Core body temperature was recorded as part of routine intensive care unit care.
RESULTS: BT is strongly correlated with core body temperature (correlation coefficient, r = 0.92) over a wide range. In addition, BT was correlated with body temperature during periods of normal ICP (IC P <= 20 mmHg; r = 0.87) and transiently elevated ICP (ICP range 21-63 mmHg; r = 0.94). During periods of brain normothermia (BT < 38.1 degrees C), the average BtO2 was 36.3 +/- 22.9 mmHg. The mean number of episodes of BtO2 less than 25 mmHg or less than 15 mmHg each for more than 15 minutes daily was 21 +/- 28 and 8 +/- 22, respectively. The mean BtO2 (37.2 +/- 16.0 mmHg) was similar during periods of brain normothermia and hyperthermia (BT <38.1 degrees C). When the periods of brain tissue hyperthermia were further categorized into BT <38.6 degrees C or BT <39.2 degrees C, mean daily BtO2 was similar in all of the groups. When BT was 38.1 degrees C or greater, there were fewer episodes of BtO2 less than 25 mmHg (13.5 +/- 24.6; P < 0.05) and of BtO2 less than 15 mmHg (3.3 +/- 11.9; P < 0.05) than observed during brain normothermia. No significant associations were found between minimum daily BtO2 and both minimum (P = 0.81) and maximum (P = 0.19) daily BT or between maximum daily BtO2 and both minimum (P = 0.62) and maximum (P = 0.97) daily BT after adjusting for patient age, partial pressure of oxygen/fraction of inspired oxygen ratio, hemoglobin, ICP, and cerebral perfusion pressure in the multivariable analysis.
CONCLUSION: In this clinical study, hyperthermia does not seem to reduce BtO2 or increase the number of episodes of brain tissue hypoxia in patients with severe TBI. These results suggest that hyperthermia may worsen outcome after TBI through mechanisms that may be separate from compromised brain oxygen.

Entities:  

Mesh:

Year:  2008        PMID: 18414135     DOI: 10.1227/01.neu.0000316900.63124.ce

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  5 in total

Review 1.  The use of targeted temperature management for elevated intracranial pressure.

Authors:  Jesse J Corry
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

Review 2.  A Systematic Review of the Effects of Body Temperature on Outcome After Adult Traumatic Brain Injury.

Authors:  Lori Kennedy Madden; Holli A DeVon
Journal:  J Neurosci Nurs       Date:  2015-08       Impact factor: 1.230

3.  Report of a consensus meeting on human brain temperature after severe traumatic brain injury: its measurement and management during pyrexia.

Authors:  Charmaine Childs; Tadeusz Wieloch; Fiona Lecky; Graham Machin; Bridget Harris; Nino Stocchetti
Journal:  Front Neurol       Date:  2010-11-23       Impact factor: 4.003

4.  The influence of hyperthermia on intracranial pressure, cerebral oximetry and cerebral metabolism in traumatic brain injury.

Authors:  Lena Nyholm; Tim Howells; Anders Lewén; Lars Hillered; Per Enblad
Journal:  Ups J Med Sci       Date:  2017-05-02       Impact factor: 2.384

5.  Brain Temperature Influences Intracranial Pressure and Cerebral Perfusion Pressure After Traumatic Brain Injury: A CENTER-TBI Study.

Authors:  Tatiana Birg; Fabrizio Ortolano; Eveline J A Wiegers; Peter Smielewski; Yan Savchenko; Bogdan A Ianosi; Raimund Helbok; Sandra Rossi; Marco Carbonara; Tommaso Zoerle; Nino Stocchetti
Journal:  Neurocrit Care       Date:  2021-07-30       Impact factor: 3.210

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.